<DOC>
	<DOCNO>NCT01523808</DOCNO>
	<brief_summary>The interest use L-asparaginase pancreatic cancer arise vitro vivo study data show anti-neoplastic effect pancreatic tumor cell line . Interestingly , study suggest additional effect L-asparaginase associate gemcitabine.GRASPA suspension red blood cell encapsulate L-asparaginase . The aim phase I clinical trial evaluate Maximum Tolerated Dose ( MTD ) GRASPA locally advance metastatic pancreatic tumor , therapy failure first second line chemotherapy use gemcitabine .</brief_summary>
	<brief_title>Administration GRASPA ( Suspension Erythrocytes Encapsulating L-asparaginase ) Patients With Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Asparaginase</mesh_term>
	<criteria>Exocrine pancreatic adenocarcinoma cytologically histologically confirm Locally advance nonresectable invasion superior mesenteric artery ( stage III ) metastatic ( stage IV ) define TNM 2002 classification ( UICC 2002 ) resistant first second line chemotherapy gemcitabine Patient age 18 70 year Signed Informed Consent Form Life expectancy â‰¥ 12 week Accurate measurement tumor volume imagery ( least one dimension ) Presence one several tumor marker ( CEA CA 19.9 ) ECOG Prognostic Score : 0 , 1 2 Patient beneficiary Social Security Insurance Patient endocrine acinar pancreatic tumor Patient know suspected cerebromeningeal metastasis Haemoglobin level great 13 g/L Patient hypersensitive Lasparaginase prior exposure form Lasparaginase Splenic vein thrombosis &lt; 3 month active treatment Antivitamin K treatment Hepatic Insufficiency unrelated pancreatic cancer Renal insufficiency unrelated pancreatic cancer Pancreatitis pancreatitis history unrelated pancreatic cancer Insulindependant diabetes mellitus unrelated pancreatic cancer Current prior coagulopathy disorder unrelated pancreatic cancer ECOG Prognostic Score 3 4 History grade 3 blood transfusion reaction ( life threaten situation ) Presence rare dangerous antierythrocyte antibody prevent get compatible pack Red Blood Cells patient Patient already include another clinical trial Pregnancy , breastfeed absence secure contraception Unwillingness sign inform consent form</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>pancreatic cancer</keyword>
	<keyword>asparaginase</keyword>
</DOC>